Segal Trials
Joseph "Scott" Fisher is an experienced psychiatric professional specializing in psychedelic facilitation and advisory roles. Currently serving as the Lead Psychedelic Facilitator at Segal Trials since July 2022 and an Advisor at INTIEM since June 2020, Fisher has a strong background in psychiatry, having worked as a Psychiatrist at Linda Berlin & Psychological Associates from July 2014 to November 2020. Prior psychiatric training includes a fellowship in Child and Adolescent Psychiatry at the University of Miami/Jackson Memorial Hospital from 2012 to June 2014 and residency at Northwestern University from July 2009 to June 2012. Fisher holds a Doctor of Medicine (MD) from Northwestern University - The Feinberg School of Medicine and a BA in Economics from the University of Chicago.
This person is not in the org chart
Segal Trials
1 followers
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.